Seres Therapeutics Raises $113M in Series E

Seres Therapeutics has successfully raised $113M in a Series E at a $450M valuation led by Flagship Pioneering, Polaris Partners, Fidelity, Nestle Health Science, Takeda Ventures.

Company Overview

Seres Therapeutics is a Biotech company headquartered in 200 Sidney Street, Cambridge, MA 02139, founded in 2010 with 250+ employees.

Microbiome therapeutic platform

Fundraising Details

Amount Raised: $113M
Round Type: Series E
Valuation: $450M
Date: 2024-01-19
Investors: Flagship Pioneering, Polaris Partners, Fidelity, Nestle Health Science, Takeda Ventures

About Seres Therapeutics

Microbiome therapeutic platform The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: 200 Sidney Street, Cambridge, MA 02139
Founded: 2010
Team Size: 250+
Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Seres Therapeutics's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Seres Therapeutics's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $450M valuation marks an important milestone for Seres Therapeutics, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Seres Therapeutics is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2024-01-19. For more information about Seres Therapeutics, visit their headquarters at 200 Sidney Street, Cambridge, MA 02139.